Ingen Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IGNT research report →
About the company
Ingen Technologies, Inc. engages in the manufacture of respiratory medical devices. Its products include oxygen flow meters and nasal cannulas that trade under the trademark name of Oxyview and Smart Nasal Cannula.
- CEO
- Gary Tilden
- IPO
- 1995
- Employees
- 155
- HQ
- Riverside, CA, US
Price Chart
- Market Cap
- $4.48K
- P/E
- -0.13
- P/S
- 330.26
- P/B
- -0.01
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
- Gross Margin
- 95.70%
- Op Margin
- -4821.23%
- Net Margin
- -7460.38%
- ROE
- 0.02%
- ROIC
- 276.67%
- Revenue
- $13.565 · -99.79%
- Net Income
- $-1,012 · 99.87%
- EPS
- $-0.00 · 80.00%
- Op Income
- $-654
- FCF YoY
- 116.77%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -6.18
- Avg Volume
- 21
Get TickerSpark's AI analysis on IGNT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IGNT coverage
Recent articles, reports, and earnings notes.
No research on IGNT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IGNT report →Similar companies
Peers in the same neighborhood.